BK virus (BKV), a human polyomavirus closely related to JC virus and Simian Virus 40, is ubiquitous in human populations worldwide. After primary infection, BKV establishes a lifelong latent infection in many organs. BKV transforms rodent cells to the neoplastic phenotype and is highly oncogenic in rodents. This review considers the oncogenic potential of BKV in humans and its possible involvement in human tumors. BKV sequences and T antigen (Tag) are detected in several types of human neoplasms, although the viral load is generally low, with less than one copy of the viral genome per cell. The possible causative role of BKV in human oncogenesis rests on the ability of BKV Tag to inactivate the functions of tumor suppressor proteins p53 and pRB family as well as on its ability to induce chromosomal aberrations in human cells. A 'hit and run' mechanism and secretion of paracrine growth factors by BKV Tag-positive cells, recruiting into proliferation neighboring and distant cells, are discussed as possible BKV pathogenic elements in human oncogenesis.
Introduction
The role of the human polyomavirus BK (BKV) in human malignancy is still debated. The specific association of BKV with human tumors is hidden by its ubiquity in the human population and by the presence of BKV DNA sequences in many normal human tissues during the lifelong latent infection which follows BKV primary infection. To solve this problem, we should acknowledge that the classical Koch's postulates are not applicable to ubiquitous viruses that produce a persistent/latent infection. New rules should be considered for these viruses in order to establish their oncogenic role in humans (zur Hausen, 1994 Hausen, , 2001 Barbanti-Brodano et al., 1998) : (i) presence and persistence of the virus or its nucleic acid in tumor cells; (ii) cell immortalization or neoplastic transformation after transfection of the viral genome or its subgenomic fragments; (iii) demonstration that the malignant phenotype of the primary tumor and the modifications induced by transfection of cultured cells depend on specific functions expressed by the viral genome; (iv) epidemiological and clinical evidence that viral infection represents a risk factor for tumor development. This review will show that BKV may fulfill at least the first three criteria and suggest that it may cooperate as a cofactor to the induction or progression of human tumors. We will consider the natural history of BVK infection, the role of BKV tumor antigens in neoplastic transformation, the experimental transformation and oncogenicity as well as the evidence for the association of BKV with human tumors. A critical appraisal will be dedicated to recent results concerning novel mechanisms of transformation induced by polyomaviruses in human oncogenesis.
Characteristics of BKV infection in humans
The natural history of BKV infection in humans has been described extensively in previous reviews (Monini et al., 1995a; Barbanti-Brodano et al., 1998; Corallini et al., 2001) . BKV is ubiquitous in human populations worldwide (Padgett and Walker, 1976) except in some segregated populations living in isolated regions of Brazil, Paraguay and Malaysia (Brown et al., 1975) . Primary infection by BKV is usually inapparent and only occasionally may be accompanied by mild respiratory illness or urinary tract disease. During primary infection, viremia occurs and the virus spreads to several organs of the infected individual where it remains in a latent state. Clinical studies, carried out in immunosuppressed and immunocompetent persons, indicate that the reactivation of BKV from latency is mainly associated with immunological impairment (Padgett and Walker, 1976) .
Virus isolation and Southern blot hybridization analysis established that the kidney is the main site of BKV latency in healthy individuals. In this respect, BKV behaves like the other primate polyomaviruses JC virus (JCV) and Simian Virus 40 (SV40), which are renotropic in humans and monkeys (Barbanti-Brodano et al., 1998; Li et al., 2002) . By these technical approaches, BKV sequences were also detected in other organs, such as liver, stomach, lungs, parathyroid glands and lymph nodes (Israel et al., 1978; Pater et al., 1980) . The detection of BKV DNA in tonsils (Goudsmit et al., 1982) suggests that the oropharynx may be the initial site of BKV infection. In addition, BKV replication was shown in human lymphocytes (Portolani et al., 1985) : therefore, the lymphoid tissue of Waldayer's ring may be involved in primary BKV infection. Infected lymphocytes could then carry BKV to the bloodstream, allowing virus transport to other organs. The PCR technology disclosed BKV DNA and RNA in brain, peripheral blood mononuclear cells (Elsner and Do¨rries, 1992; De Mattei et al., 1994 , 1995 Do¨rries et al., 1994; Dolei et al., 2000) , kidney, bladder, prostate, uterine cervix, vulva, lips and tongue (Monini et al., 1995a) . The results obtained by PCR indicate that BKV can establish latent infection in many more organs and cells than previously thought. This evidence may have important consequences on the routes and mechanisms of virus transmission, as well as on the epidemiology and reactivation of BKV latent infection. Inflammatory syndromes affecting several organs were described after BKV infection or reactivation in both immunosuppressed and immunocompetent individuals (Bratt et al., 1999; Cubukcu-Dimopulo et al., 2000; Nickeleit et al., 2000; Reploeg et al., 2001 ). An association between hemorrhagic cystitis and BKV was shown in immunosuppressed bone marrow transplant recipients (Azzi et al., 1994) . Hemorrhagic cystitis and encephalitis are caused by BKV also in immunocompetent people (Stoner et al., 2002) .
Little is known about the modality of virus transmission and the ways of access to susceptible tissues, although induction of upper respiratory disease by BKV and detection of latent BKV DNA in tonsils (Goudsmit et al., 1982) indicate a possible oral or respiratory route of transmission. The presence of BKV DNA in both maternal and fetal tissues was demonstrated by PCR, suggesting transplacental BKV infection (Pietropaolo et al., 1998) . Recently, BKV, JCV, and SV40 were detected in sewage samples of different countries over the world (Bofill-Mas et al., 2001; Vastag, 2002) . Previous evidence had already shown that SV40 was excreted in feces of subjects vaccinated with SV40-contaminated poliovaccines (Melnick and Stinbaugh, 1962) . The polyomaviruses isolated from sewage display a considerable resistance to trypsin and acid pH as well as a long survival in sewage material, suggesting a possible transmission of these viruses by the oro-fecal route. Indeed, the ingestion of contaminated water or food could represent a portal of entrance of polyomaviruses into the human population. These epidemiological data are relevant to the recent evidence of association of JCV with colorectal tumors (Laghi et al., 1999; Ricciardiello et al., 2001) . It would be interesting to analyse whether BKV and SV40 are also involved in intestinal tumorigenesis.
Role of BKV tumor antigens in transformation and oncogenicity
The early region of the BKV genome encodes the two viral oncoproteins which behave as activated oncogenes: the large T antigen (Tag) and the small t antigen (tag). BKV Tag, like JCV and SV40 Tag, displays multiple functions that alter the normal physiological metabolism of cells, ultimately leading to immortalization and neoplastic transformation (Imperiale, 2000 (Imperiale, , 2001 . The main property of Tag in relation to transformation and oncogenicity is its ability to bind and block the functions of tumor suppressor proteins p53 and pRB family (p105 RB1, p107 and p130 RB2) (Dyson et al., 1989 (Dyson et al., , 1990 Kang and Folk, 1992; Harris et al., 1996) . Consistent with a continuous need for such interactions, persistent expression of a functional Tag has been shown to be required for the maintenance of BKV transformation in hamster and mouse cells (Nakashatri et al., 1988) . As to the ability of BKV Tag to bind the pRB family proteins, the amount of BKV Tag normally produced in BKVtransfected simian BSC-1 cells seems to be too low to bind a significant amount of proteins of the pRB family (Harris et al., 1996) . BKV Tag readily binds the p53 protein available in the cell and induces serumindependence, but is unable to allow anchorage-independent growth in semisolid medium (Harris et al., 1996) . These data support the notion that BKV Tag can affect cellular growth control mechanisms, but other additional events are required for full transformation of primate cells by BKV. In addition, human p53 binds to BKV DNA in the region of the early viral promoter (Shivakumar and Das, 1996) , probably modulating the expression of BKV oncoproteins. It was shown recently that the complex of SV40 Tag with mouse p53 completely blocks the transactivating effect of the p53 protein, whereas the same complex in human cells allows human p53 to exert partially its transcriptional activity (Sheppard et al., 1999) . Owing to the high homology between the Tag of SV40 and of human polyomaviruses BK and JC, it is possible that the difficulty to induce full transformation of human cells by SV40 and human polyomaviruses is because of the inability of their Tags to block completely the effect of human tumor suppressor proteins pRB and p53.
Moreover, BKV may lead to transformation through functions independent from inactivation of tumor suppressor proteins. In fact, BKV induces mutations in rodent and human cells (Theile and Grabowski, 1990) . As SV40 Tag, which induces chromosomal damage in human cells (Ray et al., 1990; Stewart and Bacchetti, 1991) , BKV Tag induces numerical and structural chromosomal alterations in human embryonic fibroblasts, characterized by gaps, breaks, dicentric and ring chromosomes, deletions, duplications and translocations. Chromosome damage in human cells transfected with BKV early region was evident before the appearance of immortalization and of the morphologically transformed phenotype (Trabanelli et al., 1998) , suggesting that it is a cause rather than a consequence of transformation. Similar alterations were observed in cell lines from human glioblastoma multiforme, harboring the Tag coding sequences of both BKV and SV40 . The molecular mechanism of the clastogenic effect of BKV Tag is not clear at present. It may reside in its ability to bind topoisomerase I (Simmons et al., 1996) and in its helicase activity (Dean et al., 1987) which could induce chromosome damage when unwinding the two strands of cellular DNA. Moreover, since BKV Tag binds the p53 protein inactivating its functions (Kang and Folk, 1992; Harris et al., 1996) , the direct clastogenic effect of the viral oncoprotein in human cells may be enhanced, because it inhibits p53-induced apoptosis and allows DNA-damaged cells to survive, increasing their probability to transform and acquire immortality. The clastogenic and mutagenic activities of BKV may hit genes that are crucial in oncogenesis, such as oncogenes, tumor suppressor genes and DNA repair genes. Since BKV is latent in many human organs, the expression of BKV Tag in host cells during the lifelong period of latency may induce a chromosomal damage responsible for the initiation and/or progression of an oncogenic process involving BKV latently infected cells.
The knowledge about BKV small tag functions are rather scarce. Small tag cooperates with large Tag in transformation by reducing serum dependence of transformed cells (Bouck et al., 1978; Sleigh et al., 1978; Martin et al., 1979; Frisque et al., 1980) . Indeed, a low efficiency of stable transformation and a reduced incidence of tumors with a longer latency period was observed with BKV-IR (Pagnani et al., 1986) , a BKV strain bearing a deletion of 253 bp which removes sequences coding for the carboxyl-terminus of small tag (Caputo et al., 1983) . Moreover, BKV small tag binds the catalytic (36-kDa) and regulatory (63-kDa) subunits of protein phosphatase 2A (PP2A) (Rundell et al., 1981) , inactivating their function. PP2A is a serine/threonine phosphatase that regulates the phosphorylation signal activated by protein kinases (Baysal et al., 1998) and has recently been shown to be a tumor suppressor gene involved in lung, colon, breast carcinoma and melanoma (Wang et al., 1998; Calin et al., 2000) . PP2A binding may be an important function related to the mechanisms of viral transformation, since it is conserved in small DNA tumor viruses. Indeed, polyoma virus small t and middle T antigens as well as SV40 small tag (which shows 80% homology to BKV small tag) and adenovirus protein E4 bind PP2A (Pallas et al., 1990; Walter et al., 1990; Beck et al., 1998) . In the case of polyoma virus and SV40, it was shown that the region of small tag binding to PP2A is not part of the large Tag (Beck et al., 1998) , suggesting that PP2A binding is a specific function of small tag. In addition, SV40 small tag is able to enhance transcription of E2F-activated promoters of early growth response genes (Beck et al., 1998; Loeken, 1992) .
In vitro transformation by BKV
BKV, complete BKV DNA and subgenomic BKV DNA fragments containing the early region are able to transform embryonic fibroblasts and cells cultured from kidney and brain of hamster, mouse, rat, rabbit and monkey (for review see Corallini et al., 2001) . In these transformation experiments, essentially all cells in the culture express BKV Tag in their nuclei. A recombinant DNA containing the BKV Tag gene and the activated c-Ha-ras oncogene (pBK/c-rasA) induced neoplastic transformation of early-passage hamster embryo cells with greater efficiency than each of the two genes transfected independently. In addition, cells transformed by pBK/c-rasA have a more definite transformed phenotype and more advanced growth characteristics than cells transformed separately by each of the two genes , suggesting a synergic effect between BKV Tag and c-Ha-ras. Transformation of rat pancreatic islet cells, a natural target of BKV-tumorigenesis in rodents, has been described (Haukland et al., 1992) . However, human pancreatic islet cells persistently infected with BKV did not display a transformed phenotype (van der Noordaa et al., 1986), although BKV is frequently present in human islet cell tumors (Corallini et al., 1987b) .
Transformation of human cells by BKV is inefficient and often abortive (Shah et al., 1976; Portolani et al., 1978) . BKV-infected or -transfected human cells generally do not display a completely transformed phenotype, characterized by immortalization, anchorage independence and tumorigenicity in nude mice, although they show morphological alterations and an increased lifespan (Purchio and Fareed, 1979; Grossi et al., 1982) . A fully transformed phenotype was observed in human embryo kidney (HEK) cells transfected with a recombinant plasmid containing BKV early region and the adenovirus 12 E1A gene (Vasavada et al., 1986) . These cells grow as a continuous cell line suggesting that, at least in human cells, BKV Tag is competent to contribute only a partially transformed phenotype and must interact with other oncogene functions to induce a complete transformation. The recombinants pBK/c-rasA and pBK/c-myc induced morphologic transformation of human embryo fibroblasts and kidney cells, but transformed cells were not immortalized (Pater and Pater, 1986; Corallini et al., 1991) . Tumorigenic cell lines were established only from transformed human fetal brain cells persistently infected by BKV. Fetal brain cells had all the characteristics of transformed cells and retained viral DNA in an episomal state but they were negative for Tag expression (Takemoto et al., 1979) .
BKV experimental oncogenicity
BKV is highly oncogenic in rodents (for review see Corallini et al., 2001) . Young or newborn hamsters, mice and rats, inoculated with BKV through different . However, both in immunocompetent and in immunosuppressed hamsters, ependymomas, tumors of pancreatic islets and osteosarcomas were the most frequent histotypes, suggesting that BKV may have a marked tropism for specific organs. Tumors induced by BKV in mice and rats were fibrosarcoma, liposarcoma, ostesarcoma, nephroblastoma, glioma and choroid plexus papilloma, the latter arising only in mice (Corallini et al., 1977; Noss et al., 1981; Noss and Stauch, 1984) . Moreover, transgenic mice expressing BKV Tag developed hepatocellular carcinoma, renal tumors and lymphoproliferative disease (Small et al., 1986; Dalrymple and Beemon, 1990 ). Gardner's BKV strain seems to be more oncogenic than other isolates, such as MM, BKV-IR or RF (Costa et al., 1976; Dougherty, 1976; Caputo et al., 1983) . It has been shown that the induction of different tumors may reflect the presence of several viral variants in the same inoculum . In particular, an insulinoma inducing variant has been associated with a viable deletion mutant originated in a Gardner BKV stock after several passages in culture (Watanabe et al., , 1982 . A key role for viral genetic heterogeneity is further suggested by the oncogenic properties of BKV-IR, a variant rescued from a human insulinoma (Caputo et al., 1983) and associated with other human tumors (Negrini et al., 1990) . Tumors induced by BKV-IR in hamsters develop at a lower frequency but display a more malignant phenotype than tumors induced by wild-type BKV (Negrini et al., 1990) . Purified BKV DNA is not oncogenic after s.c. or i.v. inoculation and induces tumors at a very low frequency when inoculated i.c. in rodents . It displays, however, a strong synergism with activated oncogenes. The recombinant DNA pBK/c-rasA, made up of the BKV Tag gene and the activated c-Ha-ras oncogene, produced highly undifferentiated, rapidly growing, malignant sarcomas by subcutaneous inoculation in newborn hamsters, whereas the two genes independently or BKV DNA linked to the normal c-Ha-ras protoncogene were not tumorigenic (Corallini et al., 1987a) . The same recombinant pBK/c-rasA induced brain tumors upon intracerebral inoculation in newborn hamsters . BKV DNA sequences were found in all tumors examined, either integrated into the cell genome or in a free episomal state.
Potential role of BKV in human tumors
The role of BKV in human neoplasia is still uncertain, due to conflicting reports (Lednicky and Butel, 1999) . Fiori and Di Mayorca (1976) found BKV DNA sequences by DNA-DNA reassociation kinetics in five of 12 human tumors and three of four human tumor cell lines. These results were confirmed by Pater et al. (1980) , whereas three other reports failed to support these findings (Israel et al., 1978; Wold et al., 1978; Grossi et al., 1981) . These tumors contained full-length BKV genomes, but also rearranged and defective BKV DNA molecules. Since BKV shows a specific oncogenic tropism for the ependymal tissue, endocrine pancreas and bones in rodents (Corallini et al., 1977 Uchida et al., 1979; Chenciner et al., 1980) , BKV DNA sequences were searched by Southern blotting in those rare types of human tumors most frequently induced by BKV in experimental animals such as ependymomas and other brain tumors, insulinomas and osteosarcomas. BKV DNA was detected in a free, episomal state and generally at a low copy number (from 0.2 to 1 genome equivalent per cell) in 19 out of 74 (26%) human brain tumors and in four out of nine (44%) human tumors of pancreatic islets (Corallini et al., 1987b) . A number of tumors expressed BKV-specific RNA and Tag. Furthermore, a BKV variant DNA, BKV-IR, was detected by Southern blot hybridization in a human insulinoma (Caputo et al., 1983) . Virus was rescued by transfection of human embryonic fibroblasts with tumor DNA. The genome of BKV-IR contains an IS-like structure (Pagnani et al., 1986) , a type of stem-loop transposable element able to integrate and excise from the host genome (Calos and Miller, 1980) . The IS-like sequence of BKV-IR incorporates in its loop two of the early region transcriptional enhancer repeats (Pagnani et al., 1986) . It may promote cell transformation by excision from viral DNA and insertion into the cell genome, thereby specifically activating the expression of cellular oncogenes or more generally as a mutagen by random integration into the cell genome. In another study, BKV DNA was detected by Southern hybridization in 46% of brain tumors of the most common histotypes (Do¨rries et al., 1987) . In this report, BKV DNA sequences were found to be integrated into chromosomal DNA. Tumors typically associated to immunosuppression were also investigated by Southern hybridization and BKV DNA was detected in Kaposi's sarcoma (KS) at a frequency of 20% (Barbanti-Brodano et al., 1987 . Infectious BKV DNA was rescued from two KS tissues by transfection of cellular DNA into human embryonic fibroblasts (Negrini et al., 1990) .
More recently, tumors, tumor cell lines and normal human tissues were investigated by PCR using specific primers for early region BKV DNA. In most of these studies, the amount of viral DNA detected in human tissues was low, generally less than one genome equivalent per cell. The results of the studies conducted by Southern blot hybridization and PCR are summarized in Table 1 which reports positive and negative data, relative to human tumors of different histotypes, obtained by various authors. Nucleotide sequence analysis of seven brain tumors, one osteosarcoma, two glioblastoma cell lines, one normal brain and one normal bone tissue specimen confirmed that the amplified sequences correspond to the expected fragment of BKV early region (De Mattei et al., 1995) . Expression of BKV early region was detected by Northern blot analysis or RT-PCR in several tumors, tumor cell lines and normal tissues (De Mattei et al., 1995) (Table 1) . In one study, SV40 and BKV sequences were searched in human brain tumors. All the tumors harboring SV40 sequences were coinfected by BKV , suggesting a possible helper function of BKV to support SV40 infection of human cells. In another study, Flaegstad et al. (1999) detected BKV DNA by PCR in 18 neuroblastomas and in none of five normal adrenal gland samples (Table 1 ). The presence of BKV DNA was confirmed by in situ hybridization in the tumor cells of 17 of the same neuroblastomas. The expression of BKV Tag was detected by immunohistochemistry and immunoblotting in tumor cells, but not in normal control samples. Finally, BKV Tag and p53 were coimmunoprecipitated and colocalized in tumor cells by double immunostaining, suggesting a block of p53 functions by BKV Tag. These results were recently challenged by a study demonstrating that the anti-BKV Tag monoclonal antibody MAB8505, used by Flaegstad and colleagues to carry out immunoblotting for BKV Tag, strongly cross reacts with a cellular antigen, the Ku autoantigen (Zambrano and Villarreal, 2002) . Zambrano and Villarreal, however, did not control for the presence of BKV sequences in the tumor cell lines they used to detect the reactivity of MAB8505 with the Ku autoantigen. Indeed, owing to the ubiquity of BKV in human tissues and to the frequent presence of BKV sequences in human tumors, this control should have been introduced in their immunological tests. In addition, Flaegstad and colleagues showed negative results for BKV Tag in their immunoblotting assays of normal adrenal medulla lysates, used as a control.
PCR amplification of DNA sequences from BKV early and regulatory regions was carried out in urinary tract tumors. Positive samples were 31 out of 52 (60%), with a range of 50-67% in different tumor types (Monini et al., 1995b) . In addition, BKV DNA sequences were amplified by PCR in carcinomas of the uterine cervix, vulva, lips and tongue (Monini et al., 1995a (Monini et al., , 1996 . The percentage of positive samples in the neoplastic tissues of the urinary and genital tracts and of the oral cavity was similar to that detected in the corresponding normal tissues (61 and 59% respectively). However, in tumors of the urinary bladder and prostate, two-dimensional gel electrophoresis and Southern blot hybridization analysis showed either a single integration of BKV DNA or integrated and episomal viral sequences (Monini et al., 1995b) . In both the integrated and extrachromosomal viral sequences, the late region was disrupted. Viral episomes consisted of rearranged oligomers containing cellular DNA sequences, whose size was apparently incompatible with encapsidation within a viral particle. Attempts to rescue these viral sequences by transfection of tumor DNA into permissive cells were unsuccessful, suggesting that in these tumors the process of integration and formation of episomal oligomers produced a rearrangement of viral sequences responsible for the elimination of viral infectivity and potentially leading to stable expression of BKV transforming functions. Recently, a metastatic bladder carcinoma, arising in an immunosuppressed transplant recipient, appeared to be causally related to BKV, because high-level expression of BKV Tag was detected immunohistochemically in the primary and metastatic tumor but not in the neighboring normal urothelium (Geetha et al., 2002) . p53 was colocalized immunohistochemically with BKV Tag in the nuclei of tumor cells, suggesting stabilization and inhibition of its functions by BKV Tag binding. To our knowledge, this is the first instance where a selective localization of BKV Tag to tumor cells was demonstrated. The results obtained with prostate and bladder carcinoma, in connection with the evidence that the kidney is the main site of BKV latency, suggest that tumors of the urinary tract are among the best candidates for an etiological association with BKV. In other reports, however, the presence of BKV DNA sequences in human brain tumors, mostly malignant glioma, medulloblastoma and primitive neuroectodermal tumors, bladder carcinoma, Kaposi's sarcoma, lymphoma and acute lymphoblastic leukaemia, analysed by PCR, was not confirmed (Arthur et al., 1994; Vo¨lter et al., 1997; Mackenzie et al., 1999; Kim et al., 2002) (Table 1) . The negative results obtained by Vo¨lter and colleagues may be attributed to the use of degenerate primers, in order to detect simultaneously BKV, JCV and SV40 sequences, instead of primers specific for BKV DNA.
PCR analysis for the early and regulatory regions in 25 samples of KS (five classic, 12 African and eight AIDS-associated) revealed 100% positivity for BKV DNA sequences. Analysis by PCR of eight KS cell lines disclosed BKV DNA sequences in six of them, whereas JCV and SV40 sequences were absent (Monini et al., 1996) . In addition, BKV DNA sequences were detected in 15 out of 26 (58%) prostatic tissues and in 18 out of 19 (95%) seminal fluids (Monini et al., 1996) , suggesting that BKV may be a candidate for the sexually transmitted infectious agent which was indicated by epidemiological studies to be an important cofactor in KS (Peterman et al., 1993) . A specific role of the sexual route for BKV transmission is suggested by the presence of JCV only in four out of 19 (21%) prostatic tissues and in four out of 19 (21%) seminal fluids (Monini et al., 1996) . It is notable that polyomaviruses closely related to BKV induce angiogenic responses very similar to KS. Indeed, murine endothelial cells transformed by polyoma virus middle Tag or by SV40 Tag induce hemangiomas or highly vascularized KS-like tumors in nude mice (Williams et al., 1989; O'Connel et al., 1991) . Similar lesions are induced in nude mice by mouse brain and aortic endothelial cells transformed by BKV (A Corallini and G Barbanti-Brodano, unpublished results).
Conclusions and future perspectives
From epidemiological, in vitro, and animal studies considered in this review, demonstrating BKV latency in many human tissues, disruption of normal cell growth control by BKV large T and small t antigens, BKV transformation and oncogenicity, it appears that BKV has the potential to be a cofactor in induction and/or progression of human tumors. The oncogenic risk related to BKV infection could be established by an epidemiological survey on the incidence of tumors associated to BKV in segregated human populations of Brazil, Paraguay and Malaysia, which are not infected by BKV (Brown et al., 1975) . A 'hit and run' mechanism could explain the low viral load and the low number of BKV Tag-positive cells in human tumors. In fact, BKV induces chromosomal aberrations and mutations in human cells before the appearance of the transformed phenotype. This effect may represent an important oncogenic mechanism and, once chromosomal alterations are fixed in the host cells, viral sequences may be dispensable for the maintenance of transformation and may be lost by the neoplastic tissues. It is possible therefore that, while continuous expression of BKV Tag is necessary for maintenance of BKV transformation in rodent cells, in human cells the transformed phenotype is maintained by mechanisms independent from stable expression of BKV oncoproteins. Another way to explain the low viral copy number in tumors would be to test whether BKV-transformed human cells secrete paracrine growth factors that could act on neighboring and distant cells, driving them into proliferation. This amplification of oncogenic signals would be compatible with the existence of tumors where only a fraction of cells contains BKV sequences and expresses BKV Tag. Evidence for this mechanism was proven in SV40-positive mesothelioma cells, where SV40 Tag induces production and release of hepatocyte growth factor and vascular endothelial growth factor (Cacciotti et al., 2001 (Cacciotti et al., , 2002 Catalano et al., 2002) . The role of Tag in these functions was demonstrated by reversion of the neoplastic phenotype of mesothelioma cell lines after transfection and expression of an antisense SV40 Tag RNA (Waheed et al., 1999) . Another proof of BKV causative role in human oncogenesis is to establish whether BKV-positive tumors do not carry mutations in the p53 and pRB family genes. Indeed, the viral oncoproteins should functionally inactivate the gene products, substituting for mutations in these tumor suppressors genes, although mutations may subsequently appear during tumor progression toward an invasive and metastatic phenotype, as it was shown to occur in genital tumors infected by human papilloma virus (Choo and Chong, 1993; Lee et al., 1994) . Finally, the presence of BKV in sewage (Bofill-Mas et al., 2001) prompts to search for a possible association between BKV and colorectal tumors, as already shown for JCV (Laghi et al., 1999; Ricciardiello et al., 2001) .
